The GLP is committed to full transparency. Download and review our 2019 Annual Report

Big Ag megamerger? Trump meets with Bayer, Monsanto CEOs

| | January 12, 2017
Werner Baumann (left), CEO of Bayer AG, and Hugh Grant, Chairman and Chief Executive Officer of Monsanto
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

Top executives of Bayer AG and Monsanto Co. met with President-elect Donald Trump Wednesday in New York to pitch the benefits of their planned deal.

The German pharmaceutical giant’s planned purchase of Monsanto is one of three planned multibillion-dollar deals set to reshape the global seed and pesticide industry. While the companies have said that combining Bayer’s broad portfolio of pesticides with Monsanto’s sector-leading capabilities in seed engineering will accelerate breakthroughs in new crops and sprays, some farmers worry that the consolidation will boost the market power of the sector’s biggest players and leave farmers with fewer choices for critical supplies, and higher prices.

Mr. Trump has previously expressed skepticism about megamergers, including AT&T Inc.’s planned purchase of Time Warner Inc., but he hasn’t weighed in on the agricultural deals.

Beyond Bayer and Monsanto, China National Chemical Corp. is pursuing a $43 billion deal for Swiss pesticide maker Syngenta AG, while Dow Chemical Co. and DuPont Co. are pursuing their own merger that would unite those companies’ seed and crop chemical businesses.

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion, and analysis. Read full, original post: Bayer, Monsanto CEOs Pitch Deal to Trump

News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend